Over the past decade, insights into the origins and behaviorof human cancers have reshaped our understanding of these diseasesand have generated advances in clinical care. The seminal featureof this research is the focus on human cancers. By using ideasand technologies originally derived from basic science laboratories,investigators have shifted the forefront of cancer researchfrom in vitro models of tumor growth to the characterizationand treatment of cancers in humans.
This issue of the Journal launches a series of reviews on themolecular origins of cancer. The goal of this series is to highlightadvances in . . . [Full Text of this Article]
Source Information
From the Dana–Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (H.J.B.).
This article has been cited by other articles:
Pang, X., Yi, T., Yi, Z., Cho, S. G., Qu, W., Pinkaew, D., Fujise, K., Liu, M.
(2009). Morelloflavone, a Biflavonoid, Inhibits Tumor Angiogenesis by Targeting Rho GTPases and Extracellular Signal-Regulated Kinase Signaling Pathways. Cancer Res.
69: 518-525
[Abstract][Full Text]
Previous
